4.7 Article

Lifelong memory responses perpetuate humoral TH2 immunity and anaphylaxis in food allergy

Journal

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Volume 140, Issue 6, Pages 1604-+

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2017.01.018

Keywords

IgE; mast cells; memory B cells; plasma cells; T(H)2; food allergy; anaphylaxis; IgG(1); peanut allergy; germinal centers

Funding

  1. Food Allergy Canada
  2. MedImmune
  3. AllerGen NCE
  4. National Institutes of Health [1R21AI105502]

Ask authors/readers for more resources

Background: A number of food allergies (eg, fish, shellfish, and nuts) are lifelong, without any disease-transforming therapies, and unclear in their underlying immunology. Clinical manifestations of food allergy are largely mediated by IgE. Although persistent IgE titers have been attributed conventionally to long-lived IgE(+) plasma cells (PCs), this has not been directly and comprehensively tested. Objective: We sought to evaluate mechanisms underlying persistent IgE and allergic responses to food allergens. Methods: We used a model of peanut allergy and anaphylaxis, various knockout mice, adoptive transfer experiments, and in vitro assays to identify mechanisms underlying persistent IgE humoral immunity over almost the entire lifespan of the mouse (18-20 months). Results: Contrary to conventional paradigms, our data show that clinically relevant lifelong IgE titers are not sustained by long-lived IgE(+) PCs. Instead, lifelong reactivity is conferred by allergen-specific long-lived memory B cells that replenish the IgE(+) PC compartment. B-cell reactivation requires allergen re-exposure and IL-4 production by CD4 T cells. We define the half-lives of antigen-specific germinal centers (23.3 days), IgE(+) and IgG(1)(+) PCs (60 and 234.4 days, respectively), and clinically relevant cell-bound IgE (67.3 days). Conclusions: These findings can explain lifelong food allergies observed in human subjects as the consequence of allergen exposures that recurrently activate memory B cells and identify these as a therapeutic target with disease-transforming potential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available